bumetanide has been researched along with DiGeorge Syndrome in 1 studies
DiGeorge Syndrome: Congenital syndrome characterized by a wide spectrum of characteristics including the absence of the THYMUS and PARATHYROID GLANDS resulting in T-cell immunodeficiency, HYPOCALCEMIA, defects in the outflow tract of the heart, and craniofacial anomalies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, H | 1 |
| Marinaro, F | 1 |
| De Pietri Tonelli, D | 1 |
| Berdondini, L | 1 |
1 other study available for bumetanide and DiGeorge Syndrome
| Article | Year |
|---|---|
Developmental excitatory-to-inhibitory GABA-polarity switch is disrupted in 22q11.2 deletion syndrome: a potential target for clinical therapeutics.
Topics: Animals; Bumetanide; DiGeorge Syndrome; Disease Models, Animal; gamma-Aminobutyric Acid; Hippocampus | 2017 |